GenoLogics and CLC bio today announced they will provide an end-to-end informatics and analysis solution, optimized for Next Generation Sequencing research that addresses both lab and data management and data analysis all within one integrated system.
This end-to-end solution will significantly impact researchers’ ability to aggregate raw data across Next Generation Sequencing experiments to get to biological meaningful results faster. From initial sample submission to final analysis, GenoLogics’ lab and data management system for genomics, Geneus, and CLC bio’s CLC Genomics Server, CLC Genomics Workbench and CLC NGS Cell integrate seamlessly to help researchers get the most out of their Next Generation Sequencing instruments.
“With this collaboration, our Enterprise Platform expands with an end-to-end workflow that couples world-class LIMS functionalities like tracking of samples and data as well as reporting, with our comprehensive Next Generation Sequencing analysis capabilities, to the obvious benefit of our customers. This way researchers can keep up with the vast volumes of sequencing data being churned out by high-throughput sequencing machines, and quickly turn the massive amounts of raw data into meaningful results,” commented Thomas Knudsen, CEO at CLC bio.